A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies

Clinical trial NCT04532203 · RECRUITING

Trial details

NCT number: NCT04532203
Sponsor: Zhejiang University
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Non-Hodgkin's Lymphoma

Start date: 2020-11-01
Primary completion: 2023-11-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.